Select a medication above to begin.
Purixan
mercaptopurine
Adult Dosing .
Dosage forms: SUSP: 20 mg per mL
Special Note
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments
ALL
- [induction tx (off-label)]
- Dose: 2.5-5 mg/kg/dose PO qd; Start: 2.5 mg/kg/dose PO qd, may incr. to 5 mg/kg/dose PO qd after 4wk; Alt: 100-200 mg PO qd; Info: decr. dose if TPMT and/or nucleotide diphosphatase (NUDT15) heterozygous deficiency; decr. dose by at least 90% if TPMT or NUDT15 homozygous deficiency
- [maintenance tx]
- Dose: 1.5-2.5 mg/kg/dose PO qd; Alt: 50-75 mg/m^2/dose PO qd; Info: use w/ methotrexate or other agents for remission maintenance; decr. dose if TPMT and/or nucleotide diphosphatase (NUDT15) heterozygous deficiency; decr. dose by at least 90% if TPMT or NUDT15 homozygous deficiency
Crohn dz (off-label)
- [75-125 mg PO qd]
- Start: 50 mg PO qd; Max: 1.5 mg/kg/day; Info: for induction or remission maintenance in mod-severe or chronically active Crohn dz or fistulizing Crohn dz tx; decr. dose if TPMT and/or nucleotide diphosphatase (NUDT15) heterozygous deficiency; decr. dose by at least 90% if TPMT or NUDT15 homozygous deficiency
ulcerative colitis (off-label)
- [75-125 mg PO qd]
- Start: 50 mg PO qd; Max: 1.5 mg/kg/day; Info: for induction or remission maintenance; decr. dose if TPMT and/or nucleotide diphosphatase (NUDT15) heterozygous deficiency; decr. dose by at least 90% if TPMT or NUDT15 homozygous deficiency
renal dosing
- [adjust dose amount, frequency]
- CrCl <50: give usual dose q36-48h; Alt: use lowest usual start dose
- HD/PD: not defined
hepatic dosing
- [adjust dose amount]
- hepatic impairment: use lowest usual start dose
Peds Dosing .
- Dosage forms: SUSP: 20 mg per mL
Special Note
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments
ALL
- [induction tx (off-label)]
- Dose: 2.5-5 mg/kg/dose PO qd; Start: 2.5 mg/kg/dose PO qd, may incr. to 5 mg/kg/dose PO qd after 4wk; Info: decr. dose if TPMT and/or nucleotide diphosphatase (NUDT15) heterozygous deficiency; decr. dose by at least 90% if TPMT or NUDT15 homozygous deficiency
- [maintenance tx]
- Dose: 1.5-2.5 mg/kg/dose PO qd; Alt: 50-75 mg/m^2/dose PO qd; Info: use w/ methotrexate or other agents for remission maintenance; decr. dose if TPMT and/or nucleotide diphosphatase (NUDT15) heterozygous deficiency; decr. dose by at least 90% if TPMT or NUDT15 homozygous deficiency
renal dosing
- [adjust dose frequency]
- CrCl <50: give usual dose q48h
- HD: give usual dose q48h, on dialysis days admin. after dialysis; no supplement; PD: give usual dose q48h; no supplement
hepatic dosing
- [adjust dose amount]
- hepatic impairment: use lowest usual start dose